Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Rite Aid : Expands Naloxone Dispensing Program in Six Additional States

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/24/2017 | 06:26am CET

By a News Reporter-Staff News Editor at Drug Week -- Rite Aid announced that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is now available at more than 630 pharmacies in Georgia, Louisiana, Tennessee, Utah, Virginia and West Virginia without a prescription, subject to state regulations. Previously, naloxone, which can be administered by injection or nasal spray, was only available with a physician's prescription (see also Rite Aid Corporation).

"As the epidemic continues to grow, as evidenced in the Centers for Disease Control and Prevention recent statistic, 91 people die every day from an opioid overdose in the United States," said Jocelyn Konrad, Rite Aid executive vice president of pharmacy. "With the ability to dispense naloxone without a prescription in more than 20 states, Rite Aid is not only showing its commitment to increasing customer access to this potentially lifesaving medication, but we are also raising awareness and helping fight drug abuse in the communities we serve."

Naloxone is also available for purchase without patient specific prescriptions at Rite Aid pharmacies in 17 additional states including: Alabama, California, Colorado, Connecticut, Idaho, Indiana, Kentucky, Massachusetts, Maryland, North Carolina, New Hampshire, New York, Ohio, Oregon, Pennsylvania, Rhode Island and Vermont.

To date, Rite Aid has trained more than 10,000 pharmacists on naloxone dispensing. Rite Aid is also working to expand its naloxone dispensing program in other states served by the Company where naloxone is currently only available with a prescription.

Rite Aid Corporation (NYSE: RAD) is one of the nation's leading drugstore chains with nearly 4,600 stores in 31 states and the District of Columbia and fiscal 2016 annual revenues of $30.7 billion. Information about Rite Aid, including corporate background and press releases, is available through the company's website at www.riteaid.com. View source version on businesswire.com: http://www.businesswire.com/news/home/20170215005679/en/

Keywords for this news article include: Antidotes, Pharmaceuticals, Drugs and Therapies, Rite Aid Corporation, Naloxone Therapy Hydrochloride.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

(c) 2017 NewsRx LLC, source Health Newsletters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
02/24 RITE AID : Expands Naloxone Dispensing Program in Six Additional States
02/23 RITE AID : Metro Council to take up Rite Aid tax remittance, River Center contra..
02/20 RITE AID : KIDCENTS Chase Home receives $5,000 grant
02/20 RITE AID : 48-year-old Pharmacist gets indicted for thieving drugs and falsifyin..
02/20 RITE AID : Three arrested after car chase
02/17 RITE AID : At least once a year
02/15 RITE AID : Expands Naloxone Dispensing Program in Six Additional States
02/15 RITE AID : Stroudsburg Rite-Aid project moves forward
02/14 RITE AID : Chase Home Receives $5,000 Grant
02/14 RITE AID : robber strikes again
More news
Sector news : Retail - Drugs without Grocery
02/28 Valeant predicts tough 2017 with revenue to decline
02/16DJRetail CEOs Meet With Trump Over Border Tax Concerns -- Update
02/15DJRetail CEOs Meet With Trump Over Border Tax Concerns
02/14DJEXPRESS SCRIPTS : Revenue Falls
02/14 Exclusive - Trump to meet with retail CEOs on taxes, infrastructure
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
02/24 Rite Aid Investors Should Take A Hard Look The Walgreens Merger Valuation Bef..
02/19 Tracking David Einhorn's Portfolio - Q4 2016 Update
02/17 Micron Technology Is A Cheap Stock - Cramer's Lightning Round (2/16/17)
02/15 Greenlight Capital ups stake in Rite Aid
02/15 Top Merger Stocks Held By Fund Managers (Mid-Q1 2017 Edition)
Advertisement
Financials ($)
Sales 2017 32 563 M
EBIT 2017 540 M
Net income 2017 62,4 M
Debt 2017 6 906 M
Yield 2017 -
P/E ratio 2017 93,02
P/E ratio 2018 52,49
EV / Sales 2017 0,41x
EV / Sales 2018 0,40x
Capitalization 6 314 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 6,92 $
Spread / Average Target 15%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & CEO-Rite Aid Stores
Bryan B. Everett Executive Vice President-Store Operations
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Steve Rempel Chief Information Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-27.18%6 314
RAIA DROGASIL SA-3.12%6 322
AIN HOLDINGS INC4.13%2 295
ADCOCK INGRAM HOLDINGS..22.22%798
ORIOLA KD OYJ-8.82%758
AUSTRALIAN PHARMACEUTI..-7.28%718
More Results